[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for patent extension for Tercicas Somatuline Depot.[ Price : $8.95]
FDA advisors say that Alpharma abuse-prevention plans for Embeda could deter some, but not all, potential abusers.[ Price : $8.95]
FDA approves an Eisai Corp. NDA for Banzel (rufinamide), indicated as adjunctive treatment of seizures associated with Lennox-Gast...[ Price : $8.95]
Altus Pharmaceuticals says it plans to submit an NDA for Trizytek (liprotamase) during the first-half of 2009.[ Price : $8.95]
FDA reports that Merck continues to experience shipping delays for Zostavax (zoster vaccine live).[ Price : $8.95]
FDA advisors recommend approval of Pain Therapeutics Remoxy with labeling that describes it as tamper-resistant rather than abuse-...[ Price : $8.95]
FDA asks an advisory panel to consider the safety and evaluation of potential new indications for dermal filler devices.[ Price : $8.95]
Federal Register Notice: FDAs Pediatric Advisory Committee will meet 12/9 to discuss an IRB referral of a clinical investigation o...